Nitazoxanide indications and usage

Revision as of 12:51, 9 January 2014 by Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Nitazoxanide}} {{CMG}}; {{AE}} {{AZ}} ==Indications and Usage== '''Diarrhea caused by Giardia lamblia or Cryptosporidium parvum''' Alinia for Oral Suspension (p...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Nitazoxanide
ALINIA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Indications and Usage

Diarrhea caused by Giardia lamblia or Cryptosporidium parvum

Alinia for Oral Suspension (patients 1 year of age and older) and Alinia Tablets (patients 12 years and older) are indicated for the treatment of diarrhea caused by Giardia lamblia or [[[Cryptosporidium parvum]].

Alinia for Oral Suspension and Alinia Tablets have not been shown to be superior to placebo for the treatment of diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients.[1]

References

  1. "ALINIA (NITAZOXANIDE) TABLET ALINIA (NITAZOXANIDE) POWDER, FOR SUSPENSION [ROMARK LABORATORIES, LC]".

Adapted from the FDA Package Insert.